Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 217

1.

Direct and indirect costs associated with epileptic partial onset seizures among the privately insured in the United States.

Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S.

Epilepsia. 2010 May;51(5):838-44. doi: 10.1111/j.1528-1167.2009.02422.x.

2.

The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.

Ivanova JI, Birnbaum HG, Samuels S, Davis M, Phillips AL, Meletiche D.

Pharmacoeconomics. 2009;27(8):681-91. doi: 10.2165/11314700-000000000-00000.

PMID:
19712010
3.

Economic burden of epilepsy among the privately insured in the US.

Ivanova JI, Birnbaum HG, Kidolezi Y, Qiu Y, Mallett D, Caleo S.

Pharmacoeconomics. 2010;28(8):675-85. doi: 10.2165/11535570-000000000-00000.

PMID:
20623993
4.

Direct and indirect costs associated with Dupuytren's contracture.

Macaulay D, Ivanova J, Birnbaum H, Sorg R, Skodny P.

J Med Econ. 2012;15(4):664-71. doi: 10.3111/13696998.2012.670678.

PMID:
22369346
5.

Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.

Pike C, Birnbaum HG, Schiller M, Sharma H, Burge R, Edgell ET.

Pharmacoeconomics. 2010;28(5):395-409. doi: 10.2165/11531040-000000000-00000.

PMID:
20402541
6.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
7.
8.

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.

Tunceli O, Wade R, Gu T, Bouchard JR, Aagren M, Luo W.

Curr Med Res Opin. 2010 Aug;26(8):1827-34. doi: 10.1185/03007995.2010.488544.

PMID:
20491613
9.

The economic burden of schizophrenia in the United States in 2002.

Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J.

J Clin Psychiatry. 2005 Sep;66(9):1122-9.

PMID:
16187769
10.

Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T.

Appl Health Econ Health Policy. 2011 Nov 1;9(6):377-87. doi: 10.2165/11592440-000000000-00000.

PMID:
21888449
11.

Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.

Kirson NY, Birnbaum HG, Ivanova JI, Waldman T, Joish V, Williamson T.

Appl Health Econ Health Policy. 2011 Sep 1;9(5):293-303. doi: 10.2165/11592430-000000000-00000.

PMID:
21875160
12.

Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.

Hamer HM, Spottke A, Aletsee C, Knake S, Reis J, Strzelczyk A, Oertel WH, Rosenow F, Dodel R.

Epilepsia. 2006 Dec;47(12):2165-72.

13.

Economic burden and co-morbidities of atrial fibrillation in a privately insured population.

Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J.

Curr Med Res Opin. 2005 Oct;21(10):1693-9.

PMID:
16238910
14.

The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.

Asche CV, Joish VN, Camacho F, Drake CL.

Curr Med Res Opin. 2010 Aug;26(8):1843-53. doi: 10.1185/03007995.2010.488037.

PMID:
20515321
15.
16.

Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.

Cohen R, Skup M, Ozbay AB, Rizzo J, Yang M, Diener M, Chao J.

J Med Econ. 2015 Jun;18(6):447-56. doi: 10.3111/13696998.2015.1021353.

PMID:
25728698
17.

Burden of venous leg ulcers in the United States.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N.

J Med Econ. 2014 May;17(5):347-56. doi: 10.3111/13696998.2014.903258.

PMID:
24625244
18.

The economic consequences of irritable bowel syndrome: a US employer perspective.

Leong SA, Barghout V, Birnbaum HG, Thibeault CE, Ben-Hamadi R, Frech F, Ofman JJ.

Arch Intern Med. 2003 Apr 28;163(8):929-35.

PMID:
12719202
19.

Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.

Birnbaum HG, Ivanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, Meletiche D.

Curr Med Res Opin. 2009 Apr;25(4):869-77. doi: 10.1185/03007990902743869 .

PMID:
19232041
20.

The direct and indirect costs among U.S. privately insured employees with hypogonadism.

Kaltenboeck A, Foster S, Ivanova J, Diener M, Bergman R, Birnbaum H, Kinchen K, Swindle R.

J Sex Med. 2012 Sep;9(9):2438-47. doi: 10.1111/j.1743-6109.2012.02810.x.

PMID:
22738380
Items per page

Supplemental Content

Support Center